Three-year follow up of term and near-term infants treated with inhaled nitric oxide

Pediatrics International

Volumn 45, Issue 3, 2003, Pages 290-293

  Ichiba, Hiroyuki ^a   Matsunami, Satoko ^b   Itoh, Fumihide ^b   Ueda, Toru ^b   Ohsasa, Yukinobu ^b   Yamano, Tsunekazu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka City Sumiyoshi Hospital   (Japan)

Author keywords

Follow up; Inhaled nitric oxide; Persistent pulmonary hypertension of the newborn; Prognosis

Indexed keywords

NITRIC OXIDE;

ARTICLE; ARTIFICIAL VENTILATION; CEREBRAL PALSY; CHILD DEVELOPMENT; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; FOLLOW UP; HEARING LOSS; HUMAN; INFANT; MORTALITY; NERVE CELL DIFFERENTIATION; NEWBORN INTENSIVE CARE; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REACTIVE AIRWAY DISEASE; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; PROGNOSIS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0042163106     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2003.01718.x     Document Type: Article

References (17)

1. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 819-20.
2. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-19.
3. Roberts JD, Fineman JR, Morin FC et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N. Engl. J. Med. 1997; 336: 605-10.
4. The Neonatal Inhaled Nitric Oxide Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N. Engl. J. Med. 1997; 336: 597-604.
5. Gothberg S, Edberg KE, Tang SF et al. Residual pulmonary hypertension in children after treatment with inhaled nitric oxide: a follow-up study regarding cardiopulmonary and neurological symptoms. Acta Paediatr. 2000; 200: 1414-19.
6. Lipkin PH, Davidson D, Spivak L, Straube R, Rhines J, Chang CT. I-NO/ PPHN Study Group. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J. Pediatr. 2002; 140: 306-10.
7. Rosenberg AA, Kennaugh JM, Moreland SG et al. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J. Pediatr. 1997; 131: 70-75.
8. The Neonatal Inhaled Nitric Oxide Group. Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the Neonatal Inhaled Nitric Oxide Study Group (NINOS). J. Pediatr. 2000; 136: 611-17.
9. Yamaguchi N, Togari H, Takase M et al. A prospective clinical study on inhaled nitric oxide therapy for neonates in Japan. Pediatr. Int. 2001; 43: 20-25.
10. Bifano EM, Pfannenstiel A. Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. Pediatrics 1988; 81: 657-61.
11. Ferrara B, Johnson DE, Chang P-N, Thompson TR. Efficacy and neurologic outcome of profound hypocapneic alkalosis for the treatment of persistent pulmonary hypertension in infancy. J. Pediatr. 1984; 105: 457-61.
12. Kusuda S, Shishida N, Miyagi N, Hirabayashi M, Kim T-J. Cerebral blood flow during treatment for pulmonary hypertension. Arch. Dis. Child. 1999; 80: F30-33.
13. Fujikawa S, Yang L, Waffarn F, Lerner M. Persistent pulmonary hypertension of the newborn (PPHN) treated with inhaled nitric oxide: preliminary hearing outcomes. J. Am. Acad. Audiol. 1997; 8: 263-8.
14. Marron M-J, Crisafi MA, Driscoll JM et al. Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn. Pediatrics 1992; 90: 392-6.
15. Dobyns EL, Griebel J, Kinsella JP, Abman SH, Accurso FJ. Infant lung function after inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatr. Pulmonol. 1999; 28: 24-30.
16. Riou Y, Storme L, Klosowski S et al. Does inhaled nitric oxide modify lung diffusing capacity and mechanics in experimental hyaline membrane disease (HMD)? Pediatr. Res. 1996; 39: 348.
17. Swaminathan S, Quinn J, Stabile MW, Bader D, Platzker ACG, Keens TG. Long-term pulmonary sequelae of meconium aspiration syndrome. J. Pediatr. 1989; 114: 356-61.